OpenLB
Open Library of Bioscience
Advanced Search
Challenge (Atlanta, Ga.)
2007;13 (2): 61-97.

Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?

Paula M Frew, Matthew Archibald, Nina Martinez, Carlos del Rio, Mark J Mulligan
Author Information
  1. Paula M Frew: Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases.
PMID: 20686675

Abstract

The HIV/AIDS pandemic continues to challenge the African American community with disproportionate rates of infection, particularly among young women ages 25 to 34 years. Development of a preventive HIV vaccine may bring a substantial turning point in this health crisis. Engagement of the African American community is necessary to improve awareness of the effort and favorably influence attitudes and referent norms. The Theory of Reasoned Action (TRA) may be a useful framework for exploration of community engagement outcomes including future attendance, community mobilization, and study participation. Within the context of HIV vaccine outreach, we conducted a cross-sectional survey in early 2007 with 175 African-American adults (>/= 18 years). Confirmatory factor analysis and structural equation modeling were performed and the findings support the potential of the model in understanding behavioral intentions toward HIV vaccine research.

References

  1. AIDS Educ Prev. 1999 Apr;11(2):93-106 [PMID: 10214494]
  2. Contemp Clin Trials. 2006 Dec;27(6):498-505 [PMID: 16962382]
  3. Fam Community Health. 2003 Apr-Jun;26(2):94-107 [PMID: 12802115]
  4. J Womens Health (Larchmt). 2007 Apr;16(3):423-8 [PMID: 17439387]
  5. Int J STD AIDS. 2006 Feb;17(2):99-102 [PMID: 16464270]
  6. Am J Community Psychol. 2005 Jun;35(3-4):169-83 [PMID: 15909793]
  7. Prev Med. 2004 Oct;39(4):804-8 [PMID: 15351549]
  8. Am J Public Health. 2001 Dec;91(12):1938-43 [PMID: 11726369]
  9. Am J Public Health. 2001 Dec;91(12):1929-38 [PMID: 11726368]
  10. Soc Behav Pers. 1998;26(4):317-27 [PMID: 12295645]
  11. Am J Geriatr Pharmacother. 2005 Sep;3(3):149-59 [PMID: 16257817]
  12. BMJ. 2007 Jun 30;334(7608):1346-8 [PMID: 17600020]
  13. AIDS. 1998 May 7;12(7):785-93 [PMID: 9619811]
  14. AIDS Care. 2006;18 Suppl 1:S1-5 [PMID: 16938668]
  15. Public Health Rep. 2003 Jul-Aug;118(4):358-65 [PMID: 12815085]
  16. J Adolesc Health. 2006 Mar;38(3):297.e1-11 [PMID: 16488829]
  17. J Community Health. 2008 Aug;33(4):259-69 [PMID: 18389351]
  18. Public Health Rep. 2005 Sep-Oct;120(5):543-8 [PMID: 16224987]
  19. Am J Public Health. 2006 Jun;96(6):970-3 [PMID: 16670228]
  20. J Natl Med Assoc. 2007 Mar;99(3):254-7 [PMID: 17393949]
  21. Can J Public Health. 2000 Nov-Dec;91(6):432-4 [PMID: 11200733]
  22. Am J Med Sci. 1998 Jan;315(1):11-6 [PMID: 9427569]
  23. AIDS Educ Prev. 2001 Aug;13(4):343-54 [PMID: 11565593]
  24. J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):210-7 [PMID: 16394854]
  25. Am J Public Health. 2001 Sep;91(9):1377-9 [PMID: 11527761]
  26. Am J Public Health. 2005 Jul;95(7):1123-7 [PMID: 15983268]
  27. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):275-84 [PMID: 10969353]
  28. J Natl Med Assoc. 2001 Dec;93(12 Suppl):14S-17S [PMID: 11798059]
  29. MMWR Morb Mortal Wkly Rep. 2006 Feb 10;55(5):121-5 [PMID: 16467777]
  30. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):359-64 [PMID: 15980699]
  31. Soc Sci Med. 2006 Sep;63(5):1143-6 [PMID: 16707200]
  32. J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):451-7 [PMID: 11035616]
  33. AIDS Educ Prev. 1998 Oct;10(5):465-80 [PMID: 9799941]
  34. Int J STD AIDS. 2004 Aug;15(8):552-7 [PMID: 15307967]
  35. J Health Commun. 2006 Mar;11(2):199-218 [PMID: 16537288]
  36. J Acquir Immune Defic Syndr. 2004 May 1;36(1):604-12 [PMID: 15097304]
  37. J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):617-24 [PMID: 16284540]
  38. PLoS Med. 2006 Feb;3(2):e19 [PMID: 16318411]
  39. Med Care. 2002 Feb;40(2):85-95 [PMID: 11802081]
  40. J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):281-8 [PMID: 11464149]
  41. Expert Opin Emerg Drugs. 2003 May;8(1):37-45 [PMID: 14610910]
  42. Women Health. 1999;30(1):53-70 [PMID: 10813267]
  43. PLoS Med. 2006 Mar;3(3):e94 [PMID: 16478295]
  44. J Urban Health. 2000 Sep;77(3):425-37 [PMID: 10976615]
  45. Psychol Health. 1996;11(5):745-55 [PMID: 12290323]
  46. Am J Public Health. 1997 Nov;87(11):1773-8 [PMID: 9366634]
  47. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):164-71 [PMID: 10048904]
  48. AIDS. 2003 Jan 24;17(2):147-56 [PMID: 12545073]
  49. Ethn Dis. 2006 Winter;16(1):281-5 [PMID: 16599384]
  50. J Gen Intern Med. 1999 Sep;14(9):537-46 [PMID: 10491242]
  51. Vaccine. 2003 May 16;21(17-18):2032-41 [PMID: 12706693]
  52. Fam Plann Perspect. 2000 May-Jun;32(3):138-44 [PMID: 10894260]
  53. Am J Public Health. 2001 Jul;91(7):1019-24 [PMID: 11441723]
  54. Arch Intern Med. 2002 Nov 25;162(21):2458-63 [PMID: 12437405]

Grants

  1. P30 AI050409/NIAID NIH HHS
  2. P30 AI050409-08/NIAID NIH HHS
  3. P30 AI050409-09/NIAID NIH HHS
  4. P30 AI050409-10/NIAID NIH HHS
Journal Article
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0communityHIVAfricanAmericanvaccineyearsmayTheoryReasonedActionHIV/AIDSpandemiccontinueschallengedisproportionateratesinfectionparticularlyamongyoungwomenages2534DevelopmentpreventivebringsubstantialturningpointhealthcrisisEngagementnecessaryimproveawarenesseffortfavorablyinfluenceattitudesreferentnormsTRAusefulframeworkexplorationengagementoutcomesincludingfutureattendancemobilizationstudyparticipationWithincontextoutreachconductedcross-sectionalsurveyearly2007175African-Americanadults>/=18ConfirmatoryfactoranalysisstructuralequationmodelingperformedfindingssupportpotentialmodelunderstandingbehavioralintentionstowardresearchPromotingVaccineResearchCommunities:ExplainPotentialOutcomesInvolvement?

Similar Articles

Cited By